Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Surgical Recovery Correlates with Single-Cell Immune Signatures

By LabMedica International staff writers
Posted on 15 Oct 2014
The activity level of a small set of immune cells during the first 24 hours after surgery provides strong clues to how quickly patients will recover from surgery-induced fatigue and pain. More...


A highly sensitive technology, called single-cell mass cytometry, enables simultaneous monitoring of large numbers of biochemical features both on the surfaces of immune cells and within the cells, providing information of what kind of cells are present and whether they are active.

Scientists at Stanford University Medical Center (CA, USA) recruited 32 otherwise healthy patients, mostly between ages 50 and 80, who were undergoing first-time hip-replacement procedures. Blood samples from these patients were drawn 1 hour before surgery, then at 1, 24 and 72 hours postsurgery and again four to six weeks after surgery. Cytometric analysis of 35 features in and on each sample's roughly half-million constituent cells yielded profiles of the cells' identities along with key activities underway inside them. Stained cells were analyzed on a CyTOF mass cytometer (DVS Sciences; Sunnyvale, CA, USA) at an event rate of 400 to 500 cells per second.

The simultaneous analysis of 14,000 phosphorylation events in precisely phenotyped immune cell subsets revealed uniform signaling responses among patients, demarcating a surgical immune signature. When regressed against clinical parameters of surgical recovery, including functional impairment and pain, strong correlations were found with signal transducer and activator of transcription (STAT3), adenosine 3′,5′-monophosphate response element–binding protein (CREB) , and nuclear factor κB (NF-κB) signaling responses in subsets of cluster of differentiation 14+ (CD14+) monocytes. The cells in question account for only about 1% to 2% of all the white blood cells found in a typical sample of a healthy person's blood, so the changes within them could easily have been missed had a less-thorough detection technology been employed.

Brice Gaudilliere, MD, PhD, a lead author of the study, said, “If we could predict recovery time before surgery even took place we might be able to see who'd benefit from boosting their immune strength beforehand, or from presurgery interventions such as physical therapy. It might even help us decide when or if a patient should have surgery.” The study was published on September 24, 2014, in the journal Science Translational Medicine.

Related Links:

Stanford University Medical Center
DVS Sciences



Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hybrid Pipette
SWITCH
Alcohol Testing Device
Dräger Alcotest 7000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.